Rituximab for Child with Chronic Relapsing Autoimmune Hemolytic Anemia-Reference-Cited by-同舟云学术

Rituximab for Child with Chronic Relapsing Autoimmune Hemolytic Anemia

Published:2010-11-17 Issue:2 Volume:28 Page:164-166
ISSN:0888-0018
Container-title:Pediatric Hematology and Oncology
language:en
Short-container-title:Pediatric Hematology and Oncology

Author:

Ansari Shahla,Tashvighi Maryam,Arbani Bahram D.,Bagher Salimi Adel,Golpaygani Mohamadreza

Publisher

Informa UK Limited

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

http://www.tandfonline.com/doi/pdf/10.3109/08880018.2010.518339

Reference9 articles.

1. Autoimmune hemolytic anemia. In: Orkin SH, Nathan DG, Ginsburg D, Look AT, eds. Hematology of Infancy and Childhood. 7th ed. Philadelphia: WB Sanders; 2009:618–632.

2. The immune haemolytic anaemias: a century of exciting progress in understanding

3. Two cases of refractory warm autoimmune hemolytic anemia treated with rituximab

4. Rituximab for warm-type idiopathic autoimmune hemolytic anemia: a retrospective study of 11 adult patients

5. Anti-CD20 monoclonal antibody for the treatment of severe, immune-mediated, pure red cell aplasia and hemolytic anemia

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-CD20 Treatment of Autoimmune Hemolytic Anemia Refractory to Corticosteroids and Azathioprine: A Pediatric Case Report and Mini Review;Case Reports in Hematology;2018-08-26

2. Invasive fungal infections in paediatric patients treated with macromolecular immunomodulators other than tumour necrosis alpha inhibitors;Mycoses;2017-04-26

3. Benefits of rituximab as a second-line treatment for autoimmune haemolytic anaemia in children: a prospective French cohort study;British Journal of Haematology;2017-04-26

4. Efficacy and safety of rituximab in auto-immune hemolytic anemia: A meta-analysis of 21 studies;Autoimmunity Reviews;2015-04

5. Correction to: Rituximab for Child with Chronic Relapsing Autoimmune Hemolytic Anemia;Pediatric Hematology and Oncology;2015-01-02